Regulis delivers drug safety compliance and supports efficient clinical development

Outsourcing clinical trial safety activities to Regulis assures compliance and puts project on track for fast registration


A US company was dissatisfied with a large global CRO’s study and drug safety management for a programme of multinational clinical trials involving a complex drug device combination therapy. These ongoing studies were pivotal to the successful registration of the treatment in the EU and US. Regulis was given responsibility for all the clinical trial safety activities.


It was vital to correctly interpret any adverse events to create the correct safety profile for the treatment during clinical development. It was imperative to ensure continued safety oversight and to upgrade the quality of safety data capture and follow-up so that safety data could be readily interrogated and made available to FDA and EMA during the development and registration processes.


Using our substantial experience in clinical trial safety procedures and data handling, Regulis acted swiftly to:

  • Deliver an efficient and quality-controlled transfer of the legacy case data

  • Implement a detailed Safety Management Plan to clarify responsibilities

  • Introduce a programme of routine updates and review for reconciliation with the CRO-held clinical database

  • Generate monthly safety reviews and benefit/risk assessments

  • Complete an urgent overhaul of the Investigator Brochure.


The switch to Regulis’ pharmacovigilance team, delivered the following benefits:

  • Full compliance with all safety obligations met

  • Provision of fast and accurate responses to regulatory agency questions

  • Building a safety profile to support efficient development and registration.

Back to Case studies